Caron Treatment Centers, a leading nonprofit addiction treatment provider based in Wernersville, Pennsylvania, announced Thursday that Caron Treatment Centers CEO and president Bradley Sorte will be stepping down at the end of February. While the organization did not provide specific reasons beyond Sorte’s personal decision, he emphasized that his departure is motivated by a desire to prioritize time with his family.
“I strongly believe in Caron’s mission, but now am of the belief that I can serve it better in a different capacity,” Sorte said in a statement. “This was a very difficult decision, but I know that it is what’s best at this time. I will forever be appreciative of the opportunity to have been CEO of the organization that saved my life.” Following his tenure as Caron Treatment Centers CEO, Sorte will remain involved with Caron as a senior advisor until August 31, helping ensure a smooth transition while continuing to contribute to the organization’s mission.
Interim Leadership and National Search
To maintain operational continuity, Caron has appointed chief operating officer Kristine Bashore and chief clinical officer David Rotenberg to split the responsibilities of CEO and president on an interim basis. Meanwhile, the organization has launched a national executive search to identify a permanent Caron Treatment Centers CEO who can lead Caron into its next phase of growth and innovation. Dr. Thomas F. Flynn, chair of Caron’s board of trustees, expressed gratitude for Sorte’s leadership: “We respect Brad’s decision to put his family first in his deliberations, and on behalf of the Caron community, I thank him for his wide-ranging contributions to Caron and the treatment field.”
Bradley Sorte’s Journey at Caron
Sorte’s journey at Caron is a story of professional growth intertwined with personal experience. He began his career with the organization in 2011 as a therapist at Caron’s Boca Raton, Florida, clinic. Over the next decade, he assumed increasingly senior roles, reflecting his dedication to the organization’s mission and his understanding of the complexities of addiction treatment. In June 2020, he became Caron’s chief strategy and growth officer, and by August 2020, he was named Caron Treatment Centers CEO, succeeding long-time leader Doug Tieman. Sorte officially assumed full leadership in July 2021, guiding the organization without Tieman’s direct involvement.
During his time as Caron Treatment Centers CEO, Sorte emphasized innovation in both clinical practices and organizational growth. He championed value-based care initiatives, strengthened partnerships with payers, and advocated for investments in technology and research to improve treatment outcomes. In 2021, he told Behavioral Health Business that Caron aimed to discover greater value in care delivery through these strategies, reflecting his forward-thinking approach to addiction treatment.
Expansion and Innovation
Under Sorte’s leadership, Caron has expanded its reach and introduced significant new programs. In Florida, Caron operates facilities in Boca Raton and Delray Beach and recently added a new mental health program to meet growing regional needs. In January, the organization opened The Keele Medical Center, a state-of-the-art facility featuring a medical detox unit, 40 residential treatment beds, neurocognitive services, a program for seniors, research initiatives, and medical education opportunities.
These expansions are complemented by initiatives at Caron’s Pennsylvania headquarters, including the Fran and Doug Tieman Center for Research, which opened in June. Together, these facilities and programs reflect Caron’s ambition to become the “Mayo Clinic of addiction treatment,” integrating cutting-edge clinical care with research, education, and innovation.
Nationwide Impact
Caron’s influence extends well beyond Pennsylvania and Florida. The organization provides services in major cities including Philadelphia, Washington, D.C., Atlanta, and New York City, serving thousands of individuals and families impacted by addiction and co-occurring mental health conditions. In the fiscal year ending June 2021, Caron employed 755 staff members and reported $101.6 million in revenue, demonstrating its substantial role in the behavioral health sector.
Looking Ahead
Bradley Sorte’s decision to step down marks the end of a significant chapter for Caron, but the organization is positioned for continued growth and innovation. With interim leadership in place and a national search underway for a new Caron Treatment Centers CEO, Caron remains focused on delivering high-quality, evidence-based addiction treatment while expanding its programs and research capabilities.
Sorte’s continued involvement as a senior advisor until August will help ensure a smooth transition while allowing him to spend more time with his family—a priority he has cited as central to his decision. His legacy includes not only the growth and expansion of Caron’s services but also his commitment to improving care through strategic innovation, research, and clinical excellence.
As Caron moves forward, its mission remains clear: to provide life-changing addiction treatment that integrates research, education, and clinical care, helping individuals reclaim their lives and supporting families in the journey toward recovery. The search for a new Caron Treatment Centers CEO will define the next chapter, building on Sorte’s legacy and shaping the future of addiction treatment nationwide.
